August 31, 2023
Podcast: Forecasting the Impact of Medicare Part D Drug Negotiations 8/31/23
Don’t know what to think about the regulatory and competitive implications of Medicare negotiating the prices of 10 drugs with pharmaceutical companies? We had some thoughts on the new episode of the 4sight Health Roundup podcast.
- David W. Johnson is CEO of 4sight Health.
- Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.
- David Burda is News Editor and Columnist of 4sight Health.
Listen below or on YouTube.
For a transcript of this podcast, download the PDF.